Cargando…
An evaluation of the real world use and clinical utility of the Cxbladder Monitor assay in the follow-up of patients previously treated for bladder cancer
BACKGROUND: Surveilling recurrent urothelial carcinoma (UC) requires frequent cystoscopy, which is invasive, expensive and time-consuming. An accurate urinary biomarker has the potential to reduce the number of cystoscopies required during post-treatment surveillance. OBJECTIVE: To audit the clinica...
Autores principales: | Koya, Madhusudan, Osborne, Sue, Chemaslé, Christophe, Porten, Sima, Schuckman, Anne, Kennedy-Smith, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014779/ https://www.ncbi.nlm.nih.gov/pubmed/32046687 http://dx.doi.org/10.1186/s12894-020-0583-0 |
Ejemplares similares
-
Clinical Utility of Cxbladder Monitor for Patients with a History of Urothelial Carcinoma: A Physician–Patient Real-World Clinical Data Analysis
por: Lough, Tony, et al.
Publicado: (2018) -
The Diagnostic Performance of Cxbladder Resolve, Alone and in Combination with Other Cxbladder Tests, in the Identification and Priority Evaluation of Patients at Risk for Urothelial Carcinoma
por: Raman, Jay D., et al.
Publicado: (2021) -
Clinical Utility of Cxbladder for the Diagnosis of Urothelial Carcinoma
por: Darling, David, et al.
Publicado: (2017) -
Comparing CxBladder to Urine Cytology as Adjunct to Cystoscopy in Surveillance of Non-muscle Invasive Bladder Cancer—A Pilot Study
por: Chai, C. A., et al.
Publicado: (2021) -
Sex-specific Augmentation of Treatment Responses in Bladder Cancer
por: Chang, Kevin, et al.
Publicado: (2022)